Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123190573 | 12319057 | 3 | F | 20150615 | 20160627 | 20160429 | 20160701 | EXP | PHHY2016DE043569 | NOVARTIS | 0.00 | E | F | Y | 62.00000 | KG | 20160702 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123190573 | 12319057 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 180 | MG | 22334 | 10 | MG | TABLET | QD | ||||
| 123190573 | 12319057 | 2 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, QD | 180 | MG | 22334 | 5 | MG | TABLET | QD | ||||
| 123190573 | 12319057 | 3 | SS | EXEMESTANE RATIO | EXEMESTANE | 1 | Oral | 25 MG, QD | 475 | MG | 0 | 25 | MG | QD | |||||
| 123190573 | 12319057 | 4 | SS | EXEMESTANE RATIO | EXEMESTANE | 1 | Oral | 25 MG, QD | 475 | MG | 0 | 25 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123190573 | 12319057 | 1 | Breast cancer metastatic |
| 123190573 | 12319057 | 3 | Breast cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123190573 | 12319057 | HO |
| 123190573 | 12319057 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123190573 | 12319057 | Aortic arteriosclerosis | |
| 123190573 | 12319057 | Aortic dilatation | |
| 123190573 | 12319057 | Aortic elongation | |
| 123190573 | 12319057 | Aortic thrombosis | |
| 123190573 | 12319057 | Cholelithiasis | |
| 123190573 | 12319057 | Dyspnoea | |
| 123190573 | 12319057 | Goitre | |
| 123190573 | 12319057 | Hepatic cyst | |
| 123190573 | 12319057 | Hypoacusis | |
| 123190573 | 12319057 | Lung disorder | |
| 123190573 | 12319057 | Lung infiltration | |
| 123190573 | 12319057 | Lymphadenopathy | |
| 123190573 | 12319057 | Lymphadenopathy mediastinal | |
| 123190573 | 12319057 | Pain | |
| 123190573 | 12319057 | Pathological fracture | |
| 123190573 | 12319057 | Pericardial effusion | |
| 123190573 | 12319057 | Peripheral swelling | |
| 123190573 | 12319057 | Pleural effusion | |
| 123190573 | 12319057 | Pneumothorax | |
| 123190573 | 12319057 | Renal atrophy | |
| 123190573 | 12319057 | Renal disorder | |
| 123190573 | 12319057 | Renal failure | |
| 123190573 | 12319057 | Rib fracture | |
| 123190573 | 12319057 | Vascular calcification |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123190573 | 12319057 | 1 | 20150109 | 20150126 | 0 | |
| 123190573 | 12319057 | 2 | 20150128 | 0 | ||
| 123190573 | 12319057 | 3 | 20150108 | 20150126 | 0 | |
| 123190573 | 12319057 | 4 | 20150128 | 0 |